drugset / Trial / NCT00413348
Type 2 Diabetes and the Effect of Probiotics
Unknown
48 enrolled
Rigshospitalet, Denmark
Royal Veterinary and Agricultural University, Denmark · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
Insulin-resistance in type 2 diabetes is associated with chronic inflammation. Anti-inflammatory actions might increase sensitivity to insulin. Since some probiotics have anti-inflammatory properties, ingestion of the probiotic bacteria Lactobacillus Acidophilus NCFM might increase insulin-sensitivity. The inflammatory response to endotoxin injection and the insulin-sensitivity is examined before and after four weeks ingestion of probiotics.
Timeline
- Start
- 2006-11
- Primary completion
- —
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lactobacillus acidophilus NCFM | Other / unclassified | — | — |